Product NDC: | 58407-625 |
Proprietary Name: | STAHIST AD |
Non Proprietary Name: | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient(s): | 25; 60 mg/1; mg/1 & nbsp; CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58407-625 |
Labeler Name: | Magna Pharmaceuticals, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20111220 |
Package NDC: | 58407-625-30 |
Package Description: | 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE |
NDC Code | 58407-625-30 |
Proprietary Name | STAHIST AD |
Package Description | 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE |
Product NDC | 58407-625 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111220 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Magna Pharmaceuticals, Inc. |
Substance Name | CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 25; 60 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |